Multiple cycles of dose-intensive cyclophosphamide, etoposide, and cisplatinum (DICEP) produce durable responses in refractory non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/8281458

Download in:

View as

General Info

PMID
8281458